Cargando…

Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine

Chiral γ-amino alcohols are the prevalent structural motifs and building blocks in pharmaceuticals and bioactive molecules. Enantioselective hydrogenation of β-amino ketones provides a straightforward and powerful tool for the synthesis of chiral γ-amino alcohols, but the asymmetric transformation i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chengyu, Zhang, Lei, Cao, Liming, Xiong, Yan, Ma, Yueyue, Cheng, Ruihua, Ye, Jinxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814375/
https://www.ncbi.nlm.nih.gov/pubmed/36697664
http://dx.doi.org/10.1038/s42004-022-00678-4
_version_ 1784864118751100928
author Liu, Chengyu
Zhang, Lei
Cao, Liming
Xiong, Yan
Ma, Yueyue
Cheng, Ruihua
Ye, Jinxing
author_facet Liu, Chengyu
Zhang, Lei
Cao, Liming
Xiong, Yan
Ma, Yueyue
Cheng, Ruihua
Ye, Jinxing
author_sort Liu, Chengyu
collection PubMed
description Chiral γ-amino alcohols are the prevalent structural motifs and building blocks in pharmaceuticals and bioactive molecules. Enantioselective hydrogenation of β-amino ketones provides a straightforward and powerful tool for the synthesis of chiral γ-amino alcohols, but the asymmetric transformation is synthetically challenging. Here, a series of tridentate ferrocene-based phosphine ligands bearing modular and tunable unsymmetrical vicinal diamine scaffolds were designed, synthesized, and evaluated in the iridium-catalyzed asymmetric hydrogenation of β-amino ketones. The system was greatly effective to substrates with flexible structure and functionality, and diverse β-tertiary-amino ketones and β-secondary-amino ketones were hydrogenated smoothly. The excellent reactivities and enantioselectivities were achieved in the asymmetric delivery of various chiral γ-amino alcohols with up to 99% yields, >99% ee values, and turnover number (TON) of 48,500. The gram-scale reactions with low catalyst loading showed the potential application in industrial synthesis of chiral drugs, such as (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine.
format Online
Article
Text
id pubmed-9814375
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-98143752023-01-10 Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine Liu, Chengyu Zhang, Lei Cao, Liming Xiong, Yan Ma, Yueyue Cheng, Ruihua Ye, Jinxing Commun Chem Article Chiral γ-amino alcohols are the prevalent structural motifs and building blocks in pharmaceuticals and bioactive molecules. Enantioselective hydrogenation of β-amino ketones provides a straightforward and powerful tool for the synthesis of chiral γ-amino alcohols, but the asymmetric transformation is synthetically challenging. Here, a series of tridentate ferrocene-based phosphine ligands bearing modular and tunable unsymmetrical vicinal diamine scaffolds were designed, synthesized, and evaluated in the iridium-catalyzed asymmetric hydrogenation of β-amino ketones. The system was greatly effective to substrates with flexible structure and functionality, and diverse β-tertiary-amino ketones and β-secondary-amino ketones were hydrogenated smoothly. The excellent reactivities and enantioselectivities were achieved in the asymmetric delivery of various chiral γ-amino alcohols with up to 99% yields, >99% ee values, and turnover number (TON) of 48,500. The gram-scale reactions with low catalyst loading showed the potential application in industrial synthesis of chiral drugs, such as (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine. Nature Publishing Group UK 2022-05-19 /pmc/articles/PMC9814375/ /pubmed/36697664 http://dx.doi.org/10.1038/s42004-022-00678-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Liu, Chengyu
Zhang, Lei
Cao, Liming
Xiong, Yan
Ma, Yueyue
Cheng, Ruihua
Ye, Jinxing
Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine
title Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine
title_full Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine
title_fullStr Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine
title_full_unstemmed Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine
title_short Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine
title_sort iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (s)-duloxetine, (r)-fluoxetine, and (r)-atomoxetine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814375/
https://www.ncbi.nlm.nih.gov/pubmed/36697664
http://dx.doi.org/10.1038/s42004-022-00678-4
work_keys_str_mv AT liuchengyu iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine
AT zhanglei iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine
AT caoliming iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine
AT xiongyan iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine
AT mayueyue iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine
AT chengruihua iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine
AT yejinxing iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine